TNFRSF11A and osteosarcoma: More specifically, bone resorption in osteosarcoma due to increased osteoclastic activity associated with aberrant RANK/RANKL signaling leads to the release of growth factors from the bone matrix, such as IGF-1 and TGF-β [49].